Efg Asset Management (North America) Corp. Neurocrine Biosciences Inc Transaction History

Efg Asset Management (North America) Corp.

$724 Million
Q3 2025

A detailed history of Efg Asset Management (North America) Corp. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Efg Asset Management (North America) Corp. holds 9,305 shares of NBIX stock, worth $1.35 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

9,305

Previous 11,175 16.73%

Holding current value

$1.35 Million

Previous $1.4 Million 6.98%

% of portfolio

0.18%

Previous 0.21%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 03, 2025	SELL	$123.98 - $146.67 $231,842 - $274,272	-1,870 Reduced 16.73%	9,305 $1.31 Million
Q2 2025 Aug 05, 2025	BUY	$87.54 - $128.18 $89,816 - $131,512	1,026 Added 10.11%	11,175 $1.4 Million
Q1 2025 May 14, 2025	SELL	$107.22 - $153.29 $340,101 - $486,235	-3,172 Reduced 23.81%	10,149 $1.12 Million
Q4 2024 Feb 11, 2025	SELL	$111.62 - $139.44 $1.58 Million - $1.98 Million	-14,190 Reduced 51.58%	13,321 $1.82 Million
Q3 2024 Nov 12, 2024	SELL	$114.58 - $153.15 $640,387 - $855,955	-5,589 Reduced 16.89%	27,511 $3.17 Million

Q2 2024 Jul 25, 2024	SELL	$130.86 - $143.19 $361,697 - $395,777	-2,764 Reduced 7.71%	33,100 $4.56 Million
Q1 2024 May 13, 2024	SELL	$130.4 - $143.74 $83,064 - $91,562	-637 Reduced 1.75%	35,864 $4.95 Million
Q4 2023 Feb 08, 2024	SELL	$106.07 - $132.76 $172,575 - $216,000	-1,627 Reduced 4.27%	36,501 $4.81 Million
Q3 2023 Nov 02, 2023	BUY	$94.02 - $117.1 $36,667 - $45,669	390 Added 1.03%	38,128 $4.29 Million
Q2 2023 Jul 28, 2023	BUY	$89.53 - $104.87 $335,110 - $392,528	3,743 Added 11.01%	37,738 $3.56 Million
Q1 2023 Apr 27, 2023	BUY	$94.11 - $123.02 $420,201 - $549,284	4,465 Added 15.12%	33,995 $3.44 Million
Q4 2022 Feb 03, 2023	SELL	$106.72 - $127.06 $121,554 - $144,721	-1,139 Reduced 3.71%	29,530 $3.53 Million
Q3 2022 Oct 28, 2022	SELL	$92.03 - $107.81 $247,744 - $290,224	-2,692 Reduced 8.07%	30,669 $3.26 Million
Q2 2022 Aug 04, 2022	BUY	$75.79 - $100.07 $172,649 - $227,959	2,278 Added 7.33%	33,361 $3.25 Million
Q1 2022 Apr 26, 2022	BUY	$72.45 - $94.81 $2.25 Million - $2.95 Million	31,083 New	31,083 $2.92 Million

Others Institutions Holding NBIX

# of Institutions

725

Shares Held

102M

Call Options Held

230K

Put Options Held

477K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.9B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Efg Asset Management (North America) Corp., based on Form 13F filings with the SEC.

News

Stay updated on Efg Asset Management (North America) Corp. with notifications on news.

Account

Efg Asset Management (North America) Corp. Neurocrine Biosciences Inc Transaction History